Bearish flow noted in UroGen Pharma (URGN) with 1,067 puts trading, or 1.7x expected. Most active are Jun-25 7.5 puts and Jun-25 2.5 puts, with total volume in those strikes near 790 contracts. The Put/Call Ratio is 4.43, while ATM IV is up nearly 3 points on the day. Earnings are expected on August 13th.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on URGN:
- UroGen Faces Legal Battle Over Misleading FDA Claims
- UroGen Pharma price target lowered to $10 from $36 at Oppenheimer
- Biotech Alert: Searches spiking for these stocks today
- UroGen Pharma price target lowered to $15 from $40 at Guggenheim
- UroGen Pharma downgraded to Neutral from Buy at H.C. Wainwright